
Sign up to save your podcasts
Or


Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: R. Jeffrey Karnes, M.D.
Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each? Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
268268 ratings
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: R. Jeffrey Karnes, M.D.
Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each? Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

140 Listeners

318 Listeners

700 Listeners

500 Listeners

252 Listeners

261 Listeners

3,349 Listeners

1,157 Listeners

196 Listeners

90 Listeners

512 Listeners

363 Listeners

12 Listeners

253 Listeners

18 Listeners

15 Listeners

9 Listeners

428 Listeners

373 Listeners

45 Listeners

14 Listeners